Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.
H.R. 8205
Status: Passed House
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Sponsored by Mike Quigley (Democrat-IL-5)
Actions
Considered as unfinished business. (consideration: CR H5159)
Considered as unfinished business.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Motion to reconsider laid on the table Agreed to without objection.
Considered under suspension of the rules. (consideration: CR H4652-4654; text: CR H4653)
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules.
DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
Placed on the Union Calendar, Calendar No. 637.
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Introduced in House
Introduced in House
